Use of sodium-glucose co-transporter 2 inhibitors during the fasting of ramadan: Is there cause for concern?
Salem Beshyah(Shaikh Khalifa Medical City), Mahmoud Benbarka, Muhammad H. Farooqi(Dubai Pharmacy College), Sara Suliman(University of London)
Cited by 10
Related Papers
Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects With Diabetic Peripheral Neuropathy
|Diabetes Care|2004|136
Emirates Diabetes Society Consensus Guidelines for the Management of Type 2 Diabetes Mellitus – 2020
|Dubai Diabetes and Endocrinology Journal|2020|41
Prevalence of Diabetes among Migrant Women and Duration of Residence in the United Arab Emirates: A Cross Sectional Study
|PLoS ONE|2017|31
Management of nonalcoholic fatty liver disease in the Middle East
|World Journal of Gastroenterology|2020|31